Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 493

ASG acquires Homebot

Mortgage advice provider Homebot has been bought by ASG three years after raising seed funding from investors including Black Knight Financial Services and Axel Springer.

Jun 26, 2020

Element enlists corporates in $18m series B

Industrial data repository Element has now received $40m in total, Evonik, Schneider Electric Ventures, Honeywell and ABB having backed its latest round.

Jun 26, 2020

Lennar books room in Sonder's $170m series E

The short-term apartment provider raised the funding at a $1.3bn valuation and is seeking another $30m to close the round at $200m.

Jun 26, 2020

W3BCloud wheels out convertible debt financing

AMD and ConsenSys formed the decentralised data centre developer as a joint venture and have both contributed to a $20.5m round.

Jun 26, 2020

iTeos eyes $100m initial public offering

The 6 Dimensions Capital-backed cancer immunotherapy developer has raised more than $200m in funding and has filed to raise up to $100m.

Jun 26, 2020

CMG sees its way to $25m

Capital Markets Gateway added the funding from investors including Shea Ventures, Barclays, Citi, Goldman Sachs, JP Morgan, Morgan Stanley and Fidelity.

Jun 26, 2020

NSF picks Panchanathan as director

Sethuraman Panchanathan has been appointed the new director of the US National Science Foundation, having previously held executive positions at ASU.

Jun 26, 2020

Charles Schwab moves to Motif acquisition

Renren has exited the thematic stock investing platform in an acquisition of undisclosed size by Charles Schwab that followed $126m in funding.

Jun 25, 2020

Pionyr maps out $1.47bn Gilead deal

Gilead Sciences will invest $275m in return for a 49.9% stake as part of a deal that could see it purchase the cancer immunotherapy developer outright.

Jun 25, 2020

GV helps Sana secure $700m

Sana Biotechnology has closed its first round at more than $700m after investors including GV swung behind its vision to commercialise cell therapies.

Jun 25, 2020
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here